IBM & Novo Nordisk

IBM: IBM is leveraging automation and AI to increase productivity with its existing workforce in India, allowing it to handle more work internally. This demonstrates the efficiency gains from AI.

Novo Nordisk: Novo Nordisk's Bengaluru center is taking on a larger role in global drug launches, including preparatory work for its oral obesity pill in the United States. This indicates an increased strategic importance of its India operations.

IBM: IBM>>> India engineers are introducing AI-enabled air-quality monitoring systems and working with the government on AI adoption and upskilling initiatives.

Novo Nordisk: Novo Nordisk>>> is deploying AI across critical parts of the drug launch process, including drafting regulatory documents and analyzing safety data, aligning with global efforts to save costs.